Clinical Trials Directory

Trials / Recruiting

RecruitingNCT04336202

Watch and Wait Management on Rectal Cancer Patients Using New Swift Local Therapy

A Pilot Study of Dose-escalation Strategy of Radiotherapy Followed by Endorectal Brachytherapy With the Use of a New Rectal Applicator in Inoperable, Ederly Rectal Cancer Patients

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
45 (estimated)
Sponsor
Sir Mortimer B. Davis - Jewish General Hospital · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Within our institution, the principal investigator have acquired expertise in endorectal brachytherapy, a localized treatment for colorectal cancer. Until now a modality which uses an endorectal applicator has been used, which has certain limitations. In the context of this study, a new applicator will be used which is already approved by Health Canada for endorectal brachytherapy, thereby improving the participant's quality of life and optimizing treatment time.

Detailed description

The main goal of this study is to treat patients using external beam radiotherapy followed by endorectal brachytherapy using a new applicator. Validating the feasibility of this new applicator, assessing the treatment time required when using it, the necessary workload required and ultimately avoid the need for surgery are our main priorities. Currently, this option is still experimental, although several patients have been treated with this method during the last ten years. In this pilot study, 45 patients will be recruited, whom have medical conditions (co-morbidities) that make surgery very difficult, or patients that are refusing surgery.

Conditions

Interventions

TypeNameDescription
RADIATIONExternal beam radiotherapy + Endorectal brachytherapyIn this study, all participants will receive a treatment of external beam radiotherapy without chemotherapy, which will be followed by three (3) treatments of endorectal brachytherapy with the new applicator.

Timeline

Start date
2024-08-01
Primary completion
2025-02-01
Completion
2028-01-01
First posted
2020-04-07
Last updated
2024-03-20

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT04336202. Inclusion in this directory is not an endorsement.